Antibody Drug Conjugates Market Growth Insights 2024–2034
Market Scope The Global Antibody Drug Conjugates (ADC) market is rapidly emerging as a cornerstone of modern oncology, driven by the growing demand for targeted and precision-based therapies. Valued at US$ 10.24 billion in 2024, the market is projected to reach US$ 32.14 billion by 2034, expanding at a CAGR of 12.31% during the forecast period. ADCs combine monoclonal antibodies with highly...
0 Comments 0 Shares 50 Views 0 Reviews
Sponsored